Micromet to Present at the 12th Annual BIO CEO & Investor Conference
February 04 2010 - 8:00AM
PR Newswire (US)
BETHESDA, Md., Feb. 4 /PRNewswire-FirstCall/ -- Micromet, Inc.
(NASDAQ: MITI) today announced that the Company will participate in
the 12th Annual BIO CEO & Investor Conference, to be held
February 8th - 9th in New York City. Christian Itin, Ph.D., the
Company's President and CEO, will present a 25 minute corporate
overview on February 9th at 11:00 AM ET. The presentation will be
webcast live and may be accessed by visiting the Micromet website
at http://www.micromet-inc.com/. A replay of the webcast will also
be available on the Company's website. About Micromet, Inc.
Micromet, Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of antibody-based
therapies for the treatment of cancer. Its product development
pipeline includes novel antibodies generated with its proprietary
BiTEĀ® technology, as well as conventional monoclonal antibodies.
Two of Micromet's BiTE antibodies and three of its conventional
antibodies are currently in clinical trials. Micromet has
collaborations with a number of leading pharmaceutical and
biotechnology companies, including sanofi-aventis, Bayer Schering
Pharma, Merck Serono, MedImmune and Nycomed. Additional information
can be found at http://www.micromet-inc.com/. DATASOURCE: Micromet,
Inc. CONTACT: Jennifer Neiman, Director, Corporate Communications,
Micromet, Inc., +1-240-235-0246, Web Site:
http://www.micromet-inc.com/
Copyright